Kanta Nagakawa

Recent publications · Crossref

5 total works indexed

1. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

   · 2021 · cited 3,755x

2. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   · 2021 · cited 1,520x

3. Essential <i>Bacillus</i> <i>subtilis</i> genes

   · 2003 · cited 1,180x

4. Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory Illness

   · 1998 · cited 1,121x

5. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

   · 2022 · cited 915x

via Crossref · CC0